Intraocular Pressure Elevation after 0.7 mg Intravitreal Dexamethasone (Ozurdex(R)) Implantation: A One Year Follow-Up.
Dae Hyun Park, Seung Joo Ha, Sung Jin Lee
J Korean Ophthalmol Soc. 2015;56(6):891-899.   Published online 2015 Jun 15     DOI: https://doi.org/10.3341/jkos.2015.56.6.891
Citations to this article as recorded by Crossref logo
One-year Outcome of Intravitreal Dexamethasone Implant for Diabetic Macular Edema Patients
No Hae Park, Hyun Duck Kwak, Chang Ki Yoon, Ji Eun Lee, Min Sagong, Sang Joon Lee, Joo Eun Lee, Kun Hyung Kim, Hyun Woong Kim
Journal of the Korean Ophthalmological Society.2019; 60(2): 135.     CrossRef
Intraocular Pressure Changes in Patients with Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant Insertion
Juno Kim, Sung Jin Lee, Dong Hyun Wang
Journal of the Korean Ophthalmological Society.2018; 59(6): 519.     CrossRef
Risk Factors and Incidence of Elevated Intraocular Pressure after Dexamethasone Intravitreal Implant
Hyo Cheol Lim, Sung Who Park, Ji Eun Lee, Soo Jin Kim, Ji Woong Lee
Journal of the Korean Ophthalmological Society.2016; 57(9): 1422.     CrossRef